Latest advances in hepatitis C therapy The availability of new protease inhibitors is revolutionising the treatment of hepatitis C virus infection.…
More UK patients will now be eligible for two costly hepatitis C treatments Sofosbuvir has received the green light from NICE but will not be available to patients until August 2015, while simeprevir will only be accessible through a patient access scheme.…
Beethoven’s musical electrocardiogramsCould Beethoven have suffered from cardiac arrhythmia? His music suggests he could have.…
New roles explored for nucleoside reverse transcriptase inhibitors New research suggests nucleoside reverse transcriptase inhibitors (NRTIs) have intrinsic anti-inflammatory activity through suppression of NLRP3 inflammasome.…
Community pharmacists could screen at-risk groups for liver disease According to The Lancet’s commission, community pharmacists could play a key role in helping to improve liver disease services in primary care, say hepatology specialists.…
Novel drug could eliminate hepatitis C in 15 years Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination with other drugs.…
Liver disease: managing the complicationsComplications of liver disease include the development of clotting disorders, ascites and portal hypertension…
Liver disease pathophysiologyThe functions of the liver are wide ranging and include synthesis of clotting factors and metabolism of drugs and bilirubin; symptoms of liver disease relate to the liver’s inability to perform these functions…
How to interpret liver function tests Patients with abnormal liver function tests are encountered commonly by pharmacists. It is therefore helpful to know how to amend patients’ treatments and when such amendments might be necessary.…
